All Stories

  1. Letter: low rates of HBV serology testing in patients with chronic hepatitis C receiving direct acting antivirals - Authors’ reply

    Article • Alimentary Pharmacology & Therapeutics, October 2017, Wiley

    Marcus Maximilian Mücke

  2. Bacterial infection-triggered acute-on-chronic liver failure is associated with increased mortality

    Article • Liver International, September 2017, Wiley

    Marcus Maximilian Mücke

  3. Letter: the potential risk of HBV reactivation in patients with resolved HBV infection during direct-acting antiviral therapy - authors' reply

    Article • Alimentary Pharmacology & Therapeutics, September 2017, Wiley

    Marcus Maximilian Mücke

  4. No evidence of hepatitis B virus reactivation in patients with resolved infection treated with direct-acting antivirals for hepatitis C in a large real-world cohort

    Article • Alimentary Pharmacology & Therapeutics, June 2017, Wiley

    Marcus Maximilian Mücke

  5. Special populations: treating hepatitis C in patients with decompensated cirrhosis and/or advanced renal impairment

    Article • Liver International, January 2017, Wiley

    Marcus Maximilian Mücke